6-9 Feb., 2023，Medlab Middle East is scheduled to take place in Dubai World Trade Center, Dubai. We are waiting for you at booth #Z2.A30 with our new products and solutions, including but not limited to: rapid test, FIA analyzer, CLIA analyzer. FIA Analyzer Biotime team will show 3 star products, BIOT-YG-I, FLI-100 and FLI-600 FIA analyzers. CLIA Analyzer Biotime will show CLi-1600, which is a star product of CLIA analyzer. Diabetes Solution Diabetes is a disease of widespread concern in the world. At the fair, HLC-100 will be showcased, which is the GOLD STANDARD for the detection of HbA1c. The product has 12 detection channels and can get results within 2 minutes. In addition, there are also blood glucose, blood ketone, uric acid test instruments on display.  The test results are quick and accurate, economical and practical, and can effectively meet the needs of families. Rapid Test Besides, rapid test products will also be displayed, which can be used effectively in the diagnosis of respiratory infections,  mosquito-borne diseases and sexually transmitted diseases. 6-9 Feb., 2023，see you in Medlab Middle East, Dubai World Trade Center.

Every fall and winter, viral respiratory illnesses like the common cold and seasonal flu keep kids out of school and social activities. But this year, more children than usual are ending up at emergency departments and hospitals. Resepiratory Viral Infections like Human Adenovirus (HADV), Respiratory  Syncytial Virus (RSV) and Influenza (Flu) can be dangerous for some infants and young children. Country estimates of the number of clinical pneumonia cases among children aged less than 5 years were assembled into six WHO regions (African Region, Region of the Americas, SouthEast Asia Region, European Region, Eastern Mediterranean Region and Western Pacific Region) as well as into developing and developed regions. These aggregated results together with estimates of new episodes per child-year and the number of severe episodes are shown in the table. It is one of major public health interest to assess the distribution of these estimated 156 million episodes by regions and countries to assist planning for preventive interventions and case management at community and facility levels. Identifying respiratory viral infections can be hard since seasonal ADV, RSV and Flu viruses are characterized by a sudden onset of fever, cough, headache, muscle and joint pain, severe malaise (feeling unwell), sore throat and a runny nose. Doctors may suspect respiratory infections based on the findings of a physical exam and the time of year the symptoms occur. During the exam, the doctor will listen to the lungs with a stethoscope to check for wheezing or other abnormal sounds. With similar symptoms for ADV, RSV and Flu A/B, healthcare professionals need to quickly determine which infection is potentially present. Characteristic testing helps healthcare professionals at the point of care to quickly diagnose and differentiate infections with any of the three respiratory viruses and aid in pursuing appropriate courses of action, including patient and pandemic management decisions. Also, it enables scaling up test capacities during flu season to meet the need for extensive testing during peak periods. Xiamen Biotime offers convenient, affordable and rapid diagnostic Point-of-Care-Testing for respiratory infections such as ADV, RSV and Flu A/B. The four main uses and purposes Protect others: virus-infected individual can be isolated to prevent the spread of the virus. Differentiation between ADV, RSV and Flu A/B: A single sample can be used to distinguish between ADV, RSV and Flu A/B for fast testing of symptomatic patients. Optimize patient care: The earliest starting treatment is when the medication is most effective. Rapid testing where it is needed most: The ability to conduct testing outside the lab at any time and anywhere to support testing strategies and increase capacity. Conclusion About 156 million new episodes of childhood clinical pneumonia occurred globally in 2000, more than 95% of them in developing countries. Of all the pneumonia cases occurring in th...

November 14th-17th 2022,  for 4 days, Biotime was at the Düsseldorf Convention and Exhibition Center to demonstrate its best product lines. Biotime team introduced customized solutions to meet the needs of international customers, which are highly praised by the participants, and the results of efforts attracted lots of individuals and businesses to our company. Biotime showed fluorescent  immunoassay  analyzers  with  different  testing channels  to demonstrate  the  quantitative  concentration  of  analytes  in  human  blood  and  urine.  As well as new range of chemiluminescence immunoassay analyzers also debuted. On site, there are three popular products, and they are CLi1600, HLC100 and BIOT-YG-I. CLi-1600 is a semi-automated device which quantifies biomarkers for thyroid disease, inflammation, cardiac diseases, fertility, diabetes, bone metabolism, anemia, and health check by analyzing human serum, plasma and whole blood. High Performance Liquid Chromatography analyzer, HLC-100 is fully automatic glycated hemoglobin that measures HbA1c, HbF and other hemoglobin fragments in the blood with ultra-high precision, enabling clinicians to make rapid and accurate diagnoses to ensure timely treatment of patients. BIOT-YG-I is a single-channel immunofluorescence analyzer that measures quantitative concentrations of target analytes in human blood and urine. Biotime POCT platform covers the needs of multi-scenario use, convenient and fast, with more than 50 test projects. Biotime will continue to adhere to the corporate mission of serving health with science and technology, provide clients with high quality services and products and help the development of the global health industry. Thank you for supporting us. See you next year at Medica 2023!

14-17, Nov. 2022, the 54th Medica Exhibition will be held in the Dusseldorf Convention Center, Germany. At that time, Biotime's full range of products will be displayed. Medica is recognized as the largest hospital and medical equipment exhibition in the world. With its irreplaceable scale and influence, it ranks first place in the world medical trade exhibition. Every year, nearly 4000 exhibitors from more than 60 countries and regions gather here. On site, new automatic glycated hemoglobin analyzer, HLC-100, and six-channel chemiluminescence analyzer, CLi-1600 will make a wonderful appearance. In addition to the new chemiluminescence platform, the highly praised immunofluorescence platform will also debut. Biotiem immunofluorescence platform has covered multiple series, such as cardiovascular and cerebrovascular, inflammation, hormones, thyroid function, diabetes and kidney injury. The fastest test results can be obtained in 3mins. Biotime aims to meet the needs of different medical institutions and provides users with more comprehensive POCT solutions. It will be a great honor to welcome you to visit Hall 1, Biotime Booth G39-2

Big News Day！Biotime SARS-CoV-2 Antigen Rapid Qualitative Test has been recognized by SFDA. Saudi Food and Drug Authority (SFDA) is an independent body for the Kingdom of Saudi Arabia that aims to ensure food and drug safety for the nation.  The Saudi Ministry of Health has given it responsibility for the regulation of pharmaceuticals, and it is an influential organization among states within the region. Biotime SARS-CoV-2 Antigen Rapid Qualitative Test based on colloidal gold immunochromatography method and intend to use as the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. SFDA authoritative certification means that SARS-CoV-2 Antigen Rapid Qualitative Test is available for sale in Saudi Arabia. If you are interested in this product, please contact us.

The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has recognized the Biotime BIOT-YG-I Fluorescence Immunoassay Analyzer and the fully-automated HLC-100 High-Performance Liquid Chromatography Analyzer for their safety and qualification to detect glycosylated hemoglobin HbA1c on Big-News Day. As far as glycosylated hemoglobin detection is concerned, the IFCC is the most widely used laboratory standard. As a provider of diabetes screening, diagnosis, blood glucose control and efficacy observation tests, Biotime is dedicated to providing clinicians and patients with accurate and effective test results.

Meet Biotime on 26-28 Oct. Africa Health 2022, at the Gallagher Convention Center in South Africa! Africa Health is organized by Informa Markets，and aimed to open up the African market. Started in 2011, once a year, Africa Health is an excellent platform to promote a variety of products and expand African business. It is also an important gathering place for African and global hospitals, pharmaceutical industry, medical academic research, retailers and other professionals. During the Expo, Biotime star products immunofluorescent instruments BIOT-YG-I, FLI-100, FLI-600 will be showcased. In addition, the upcoming chemiluminescence series of new products CLI-100, CLI-1600 will also be unveiled. Welcome to come and visit Biotime booth #2.B51.

Meet Biotime on 19-21 October Asia Health 2022, at Impact Exhibition Center, Bangkok, Thailand! It will bring together more than 400 exhibitors, 2,000 experts and scholars, and 40,000 professional visitors from all over the ASEAN region. Majorly, there will be displays of fluorescent immunoassay analyzers with different channels demonstrating the quantitative concentration of analytes in human blood and urine. As well as new range of chemiluminescence immunoassay analyzers will also debut.